Plain-English translation of NCT07307664 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether oncology care teams can offer genetic testing more routinely to patients diagnosed with breast, pancreatic, or colorectal cancer. Right now, many patients who could benefit from this testing don't receive it, even though it can help guide treatment choices and alert family members to their own cancer risks.
Genetic testing for inherited cancer risks is underused in most hospitals and clinics, even though evidence shows it helps patients and their families. This study is testing new ways to make this testing a standard part of cancer care instead of something patients have to specially request.
You likely qualify if…
You likely don't qualify if…
As an oncology care team member, you would participate in implementing new strategies designed to increase how often your team offers genetic testing to eligible patients. The study will track how many patients receive genetic test orders and complete testing before and after your team adopts these new practice approaches over several phases, followed by a period to see if the changes last.
AI-generated summary from trial data · Jul 9, 2026 · Not medical advice
United States